St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Destiny Hinton
Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.
Stories by Destiny Hinton
St. Jude dentists protect patients’ smiles during and after treatment
Meet Martha Wells, DMD, MS, Chief of Dentistry at St. Jude, and learn the importance of dental health in cancer treatment
Genetic insights advance understanding of pediatric thyroid cancer
A new St. Jude study uncovers genetic factors behind pediatric thyroid cancer risk.
Technology advances unlock the mystery of mitochondrial DNA — our “other” genome
See how tools like mitoedit and NETBID reveal mitochondrial DNA (mtDNA) ties to diseases such as acute lymphoblastic leukemia
St. Jude visual artists bring research to life
Watch how St. Jude visual storytellers use artistry to support scientific discovery
Weaving palliative principles into sickle cell disease care
St. Jude clinicians collaborate with fellow palliative care experts to advocate for bringing palliative care to patients with sickle cell disease.
Collaborative science fuels innovation in immunotherapy effort to treat brain tumors
Learn about how an award-winning scientific collaboration is pushing forward novel cancer therapies.
Shaping a legacy of education and training at St. Jude
Meet Suzanne Gronemeyer, PhD, and discover how she built a legacy of education and training at St. Jude.
Master’s program helps launch data science careers at St. Jude
See how the St. Jude Graduate School of Biomedical Sciences trains students in the Applied Biomedical Data Science MS program.
Understanding critical pathways drives targeted therapy efforts
See how St. Jude scientists turn research into strategies for drugging key cancer pathways.
Studies link SMARCAL1 to increased risk for pediatric bone cancer
Two St. Jude efforts independently uncovered the predisposition gene’s role.